UCB Selects Medidata Clinical Cloud® to Support Patient-Centric Drug Development
Go back to UCB Selects Medidata Clinical Cloud® to Support Patient-Centric Drug Development| Medidata Solutions, Inc. (NASDAQ: MDSO) | Delayed: 92.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.22 | 52 Week High | $57.21 | |||
| Open | $37.58 | 52 Week Low | $30.22 | |||
| Day High | $92.22 | P/E | 297.48 | |||
| Day Low | $92.22 | EPS | $0.31 | |||
| Volume | 4,000 | |||||
| (NYSE: UCB) | Delayed: 34.89 -0.1 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.99 | 52 Week High | $ | |||
| Open | $34.63 | 52 Week Low | $ | |||
| Day High | $34.93 | P/E | N/A | |||
| Day Low | $34.33 | EPS | $ | |||
| Volume | 1,221,139 | |||||
